107 related articles for article (PubMed ID: 28053143)
1. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
Matsumoto S; Fujii S; Kikuchi A
J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
[TBL] [Abstract][Full Text] [Related]
2. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
4. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation.
Fujii S; Ishibashi T; Kokura M; Fujimoto T; Matsumoto S; Shidara S; Kurppa KJ; Pape J; Caton J; Morgan PR; Heikinheimo K; Kikuchi A; Jimi E; Kiyoshima T
J Pathol; 2022 Jan; 256(1):119-133. PubMed ID: 34622442
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of Arl4c expression in colorectal cancer.
Chen X; Su Z; Wang S; Xu H
Cancer Biomark; 2016; 16(2):253-7. PubMed ID: 26756615
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signalling in adrenal physiology and tumour development.
Berthon A; Martinez A; Bertherat J; Val P
Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188
[TBL] [Abstract][Full Text] [Related]
7. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
Fu X; Li L; Peng Y
J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
[TBL] [Abstract][Full Text] [Related]
8. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
9. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
[TBL] [Abstract][Full Text] [Related]
10. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
[TBL] [Abstract][Full Text] [Related]
11. ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.
Kanai R; Uehara T; Yoshizawa T; Kamakura M; Nakajima T; Kinugawa Y; Iwaya M; Asaka S; Kitazawa M; Nagaya T; Ota H
BMC Cancer; 2023 May; 23(1):478. PubMed ID: 37237373
[TBL] [Abstract][Full Text] [Related]
12. The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis.
Fujii S; Kiyoshima T
Pathol Int; 2023 Jun; 73(6):217-233. PubMed ID: 37098842
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
14. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylation factors 1 and 6 regulate Wnt/β-catenin signaling via control of LRP6 phosphorylation.
Kim W; Kim SY; Kim T; Kim M; Bae DJ; Choi HI; Kim IS; Jho E
Oncogene; 2013 Jul; 32(28):3390-6. PubMed ID: 22907437
[TBL] [Abstract][Full Text] [Related]
16. Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Cristóbal I; Rincón R; Manso R; Rojo F; García-Foncillas J
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136032
[No Abstract] [Full Text] [Related]
17. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
18. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures.
Matsumoto S; Fujii S; Sato A; Ibuka S; Kagawa Y; Ishii M; Kikuchi A
EMBO J; 2014 Apr; 33(7):702-18. PubMed ID: 24562386
[TBL] [Abstract][Full Text] [Related]
19. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
[TBL] [Abstract][Full Text] [Related]
20. KRAS and cancer stem cells in APC-mutant colorectal cancer.
Fearon ER; Wicha MS
J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
